Neogenomics Inc (NEO)

10:11 AM

NeoGenomics Inc. Shows Early Signs of Technical StrengthQuarterly Trade Report & High Conviction Buy Zone Picks - 선데이타임즈

10:11 AM

Aug 13, 2025

NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know - Yahoo Finance

Aug 13, 2025

Aug 13, 2025

NeoGenomics reports Q2 revenue of $181.3mln, misses estimates. - AInvest

Aug 13, 2025

Aug 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics - Bluefield Daily Telegraph

Aug 13, 2025

Aug 13, 2025

NeoGenomics Earnings Outlook: Analysts Expect $-0.01 EPS, Guidance Key to Market Reaction - AInvest

Aug 13, 2025

Aug 12, 2025

AMN Healthcare Services, NeoGenomics, Acadia Healthcare, BrightSpring Health Services, and Repligen Shares Are Soaring, What You Need To Know - TradingView

Aug 12, 2025

Aug 12, 2025

NEO Q2 Deep Dive: Guidance Reset Amid Pharma Weakness, Delayed Product Launches - Yahoo Finance

Aug 12, 2025

Aug 12, 2025

NeoGenomics’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Aug 12, 2025

Aug 12, 2025

NeoGenomics Misses Q2 Revenue Estimates, Decreases FY Guidance Amid Pharma Services Challenges and Product Launch Delays. - AInvest

Aug 12, 2025

Aug 11, 2025

Can NeoGenomics Inc. sustain its profitabilityCapital Rotation Trade Suggestions - thegnnews.com

Aug 11, 2025

Aug 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - WV News

Aug 11, 2025

Aug 09, 2025

NeoGenomics Board Member Resigns Amid Valuation Concerns - AInvest

Aug 09, 2025

Aug 08, 2025

NeoGenomics Board Member Elizabeth Floegel Resigns - TipRanks

Aug 08, 2025

Aug 07, 2025

Why NeoGenomics Inc. stock attracts strong analyst attentionBuy Low Sell High Stock Watch Strategy in Focus - metal.it

Aug 07, 2025

Aug 07, 2025

Is NeoGenomics (NEO) a Short-Term Bargain or a High-Risk Speculation? - AInvest

Aug 07, 2025

Aug 07, 2025

Why NeoGenomics (NEO) Stock Is Trading Up Today - Yahoo Finance

Aug 07, 2025

Aug 06, 2025

NEOGENOMICS Executives Make Significant Stock Purchases - TradingView

Aug 06, 2025

Aug 05, 2025

NeoGenomics (NEO) Targets Opportunity at $5 billion Liquid Biopsy Market - Insider Monkey

Aug 05, 2025

Aug 04, 2025

What are the latest earnings results for NeoGenomics Inc.Stay informed with expert market forecasts - Jammu Links News

Aug 04, 2025

Aug 04, 2025

Is NeoGenomics Inc. a good long term investmentMaximize gains with professional stock picks - Jammu Links News

Aug 04, 2025

Aug 03, 2025

What institutional investors are buying NeoGenomics Inc. stockAchieve consistent high returns with low risk - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is NeoGenomics Inc. a growth stock or a value stockInvest confidently with data-driven strategies - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell NeoGenomics Inc. stock in 2025Fastest-growing stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

NeoGenomics Inc. Stock Analysis and ForecastBuild wealth steadily with proven stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is NeoGenomics Inc. company’s balance sheetAchieve rapid wealth accumulation with smart picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is NeoGenomics Inc. company’s growth strategyGet timely advice on market trends - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes NeoGenomics Inc. stock price move sharplyDiscover market opportunities with expert help - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How volatile is NeoGenomics Inc. stock compared to the marketGet timely alerts on market opportunities - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives NeoGenomics Inc. stock priceUnlock daily market insights for better decisions - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of NeoGenomics Inc. stockBreakneck growth rates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate NeoGenomics Inc. as a “Buy”Free Popular Stock Recommendations - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does NeoGenomics Inc. stock perform well during market downturnsMaximize your returns with smart trade entries - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive NeoGenomics Inc. stock higher in 2025High-octane financial growth - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Is NeoGenomics Inc. stock overvalued or undervaluedExplosive trading opportunities - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What is the risk reward ratio of investing in NeoGenomics Inc. stockMaximize gains with data-driven stock picks - Jammu Links News

Aug 02, 2025

Aug 01, 2025

NeoGenomics launches blood-based cancer test for advanced tumors - Gulfshore Business

Aug 01, 2025

Aug 01, 2025

NeoGenomics Reports Revenue Growth Amid Rising Losses - TipRanks

Aug 01, 2025

Aug 01, 2025

NeoGenomics Earnings: Analysts Lower Price Target to $8.72 Amid Mixed Opinions on Business Prospects - AInvest

Aug 01, 2025

Aug 01, 2025

Earnings Release: Here's Why Analysts Cut Their NeoGenomics, Inc. (NASDAQ:NEO) Price Target To US$8.72 - Yahoo Finance

Aug 01, 2025

Jul 31, 2025

NeoGenomics Earnings Call: Growth Amid Challenges - The Globe and Mail

Jul 31, 2025

Jul 31, 2025

NeoGenomics, Inc. (NASDAQ:NEO) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 31, 2025

Jul 31, 2025

NeoGenomics shares rise 1.37% premarket after launching PanTracer LBx, a blood-based genomic profiling test. - AInvest

Jul 31, 2025

Jul 30, 2025

NeoGenomics outlines revised 2025 outlook with 9%-10% revenue growth target amid pharma headwinds and PanTracer launch - MSN

Jul 30, 2025

Jul 30, 2025

Analyzing recovery setups for NeoGenomics Inc. investorsLow Drawdown Real Time Trading Tips Shared - metal.it

Jul 30, 2025

Jul 30, 2025

A Glimpse Into The Expert Outlook On NeoGenomics Through 3 Analysts - 富途牛牛

Jul 30, 2025

Jul 30, 2025

NeoGenomics Downgraded to Market Perform by William Blair: Challenges in Oncology Diagnostics - AInvest

Jul 30, 2025

Jul 30, 2025

NeoGenomics Sees Potential Upside Amidst Challenges and Low Valuation - AInvest

Jul 30, 2025

Jul 30, 2025

NeoGenomics Experiences Revenue Growth Amid Rising Losses and Impairment Charges. - AInvest

Jul 30, 2025